Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(3.83)
# 681
Out of 5,072 analysts
85
Total ratings
45.24%
Success rate
11.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.36 | +238.98% | 4 | Jun 4, 2025 | |
| AURA Aura Biosciences | Assumes: Buy | $22 | $6.60 | +233.33% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $1.44 | +596.86% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $11.51 | +247.67% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.11 | +800.90% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $3.17 | +89.27% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $4.72 | +175.42% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $2 | $0.92 | +117.53% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $7.38 | +211.65% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $44.75 | +67.60% | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $9.49 | +279.35% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $6 | $2.03 | +196.30% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.00 | +1,400.00% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $8.07 | +209.79% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $44.03 | +13.56% | 13 | Nov 26, 2024 |
ImmunityBio
Jun 4, 2025
Reiterates: Buy
Price Target: $8
Current: $2.36
Upside: +238.98%
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $6.60
Upside: +233.33%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $1.44
Upside: +596.86%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $11.51
Upside: +247.67%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.11
Upside: +800.90%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $3.17
Upside: +89.27%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $4.72
Upside: +175.42%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $2
Current: $0.92
Upside: +117.53%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $7.38
Upside: +211.65%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $44.75
Upside: +67.60%
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $9.49
Upside: +279.35%
Mar 26, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $2.03
Upside: +196.30%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.00
Upside: +1,400.00%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $8.07
Upside: +209.79%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $44.03
Upside: +13.56%